Kirkland & Ellis LLP
02/10/2026 | Press release | Distributed by Public on 02/11/2026 09:59
Kirkland Assists Ascletis Pharma on its Share Placing
Kirkland & Ellis represented Ascletis Pharma Inc. (Ascletis Pharma, Stock Code: 1672) on its placing of 69,256,000 shares. The Placing was announced on February 3, 2026 and completed on February 10, 2026. Citigroup Global Markets Limited acts as its sole placing agent.
The net proceeds (after deducting the commissions and estimated expenses) from the Placing are expected to be approximately HK$835.3 million in aggregate.
Read the transaction announcement
The Kirkland team included capital markets lawyers Mengyu Lu, Justin Zhou, Sierra Tao and Claire Chen.
Kirkland & Ellis LLP published this content on February 10, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 11, 2026 at 15:59 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]